Ignite Creation Date:
2024-05-06 @ 1:53 PM
Last Modification Date:
2024-10-26 @ 1:21 PM
Study NCT ID:
NCT04152499
Status:
RECRUITING
Last Update Posted:
2024-06-24
First Post:
2019-10-29
Brief Title:
Phase I-II FIH TROP2 ADC Advanced UnresectableMetastatic Solid Tumors Refractory to Standard Therapies
Sponsor:
Klus Pharma Inc
Organization:
Klus Pharma Inc
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-02-28
Start Date Type:
ACTUAL
Primary Completion Date:
2025-08-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-07-16
Completion Date Type:
ESTIMATED
First Submit Date:
2019-10-29
First Submit QC Date:
November 1 2019
Study First Post Date:
2019-11-05
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-06-21
Last Update Post Date:
2024-06-24
Last Update Post Date Type:
ACTUAL